We are live on !
Find out more
GA
Gagnon Advisors Portfolio holdings
AUM
$157M
Turnover
26.92%
1-Year Est. Return
36.77%
This Fund
S&P 500
This Quarter Est. Return
+31.49%
1 Year Est. Return
+36.77%
3 Year Est. Return
+129.26%
5 Year Est. Return
+121.36%
10 Year Est. Return
+1,705.4%
AUM
$157M
AUM Growth
+$21.3M
(+16%)
Cap. Flow
-$4.26M
Cap. Flow % of AUM
Cap. Flow %
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
67.17%
Holding
26
New
4
Increased
5
Reduced
–
Closed
3
Avg Time Held
4.8
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Treace Medical Concepts
TMCI
|
+$4.22M |
| 2 |
QuidelOrtho
QDEL
|
+$3.18M |
| 3 |
Hinge Health
HNGE
|
+$1.77M |
| 4 |
GeneDx Holdings
WGS
|
+$1.68M |
| 5 |
Vertex
VERX
|
+$806K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Navigator Holdings
NVGS
|
+$10.4M |
| 2 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$9.6M |
| 3 |
Alpha and Omega Semiconductor
AOSL
|
+$2.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.33% |
| 2 | Technology | 18.77% |
| 3 | Industrials | 8.3% |
| 4 | Energy | 7.94% |
| 5 | Real Estate | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
CareDx
CDNA
$3.67B
| $15.6M | 9.91% |
546,893
+14,001
| +3% | +$305K |
2014 Q3
47 quarters
|
|
2
Ameresco
AMRC
$1.05B
| $13M | 8.3% |
472,798
| – | – |
2013 Q4
50 quarters
|
|
3
Enterprise Products Partners
EPD
$79.1B
| $12.5M | 7.94% |
339,877
| – | – |
2019 Q1
29 quarters
|
|
|
4
GeneDx Holdings
WGS
$2.07B
| $12.2M | 7.76% |
177,870
+29,645
| +20% | +$1.68M |
2021 Q3
19 quarters
|
|
5
Equinix
EQIX
$97.8B
| $11.2M | 7.1% |
10,715
| – | – |
2013 Q4
50 quarters
|
|
|
6
Hinge Health
HNGE
$9.02B
| $9.4M | 5.98% |
113,304
+32,517
| +40% | +$1.77M |
2026 Q1
1 quarter
|
|
7
Pacira BioSciences
PCRX
$1.45B
| $8.95M | 5.69% |
352,637
| – | – |
2019 Q2
28 quarters
|
|
8
Freshworks
FRSH
$3.87B
| $7.86M | 5% |
776,212
| – | – |
2021 Q3
19 quarters
|
|
9
DELISTED
BioLife Solutions
BLFS
| $7.74M | 4.92% |
274,217
| – | – |
2020 Q2
24 quarters
|
|
10
FIVE9
FIVN
$2.64B
| $7.17M | 4.56% |
336,277
| – | – |
2016 Q1
41 quarters
|
|
11
Profound Medical
PROF
$210M
| $6.4M | 4.07% |
962,186
| – | – |
2020 Q1
25 quarters
|
|
|
12
Treace Medical Concepts
TMCI
$266M
| $6.11M | 3.88% |
+1,534,034
| New | +$4.22M |
2026 Q2
0 quarters
|
|
13
OraSure Technologies
OSUR
$266M
| $5.39M | 3.42% |
1,207,440
| – | – |
2025 Q1
5 quarters
|
|
14
Amplitude
AMPL
$2.05B
| $4.86M | 3.09% |
634,987
| – | – |
2025 Q3
3 quarters
|
|
15
DoubleVerify
DV
$2.12B
| $4.75M | 3.02% |
438,039
| – | – |
2023 Q4
10 quarters
|
|
|
16
QuidelOrtho
QDEL
$965M
| $4.22M | 2.69% |
+241,097
| New | +$3.18M |
2026 Q2
0 quarters
|
|
|
17
Vertex
VERX
$2.37B
| $4.15M | 2.64% |
361,621
+64,571
| +22% | +$806K |
2023 Q4
10 quarters
|
|
18
BlackLine
BL
$1.84B
| $3.65M | 2.32% |
130,050
| – | – |
2018 Q3
31 quarters
|
|
19
MarineMax
HZO
$1.16B
| $3.56M | 2.26% |
97,242
| – | – |
2025 Q3
3 quarters
|
|
20
Kaltura
KLTR
$212M
| $1.84M | 1.17% |
1,413,010
| – | – |
2023 Q2
12 quarters
|
|
21
CNFinance Holdings
CNF
$31.7M
| $299K | 0.19% |
108,017
+27,658
| +34% | +$85.2K |
2018 Q4
30 quarters
|
|
22
Beyond Meat
BYND
$118M
| $292K | 0.19% |
+12,963
| New | +$302K |
2026 Q2
0 quarters
|
|
|
23
Alpha and Omega Semiconductor
AOSL
$725M
| – | – |
-120,196
| Closed | -$2.66M | – |
|
|
24
Navigator Holdings
NVGS
$1.31B
| – | – |
-539,881
| Closed | -$10.4M | – |
|
|
25
iShares 0-3 Month Treasury Bond ETF
SGOV
$116B
| – | – |
-95,621
| Closed | -$9.6M | – |
|
Similar funds
CM
Gagnon Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Gagnon Advisors held 26 positions worth $157M, up 16% from $136M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Gagnon Advisors's Q2 2026 filing shows 4 new, 5 increased and 3 closed positions. Its largest new stake was Treace Medical Concepts: 1,534,034 shares worth $6.11M. The largest sale was Navigator Holdings, an estimated $10.4M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
- Gagnon Advisors's largest Q2 2026 buy was Treace Medical Concepts: 1,534,034 shares worth $6.11M.
- Gagnon Advisors added most to Hinge Health in Q2 2026, an estimated $1.77M increase.
- Gagnon Advisors fully exited Navigator Holdings in Q2 2026, selling an estimated $10.4M.
- Gagnon Advisors's ten largest holdings make up 67% of its $157M portfolio in Q2 2026.
- Gagnon Advisors opened 4 new positions and closed 3 in Q2 2026.
- Gagnon Advisors's portfolio value rose 16% quarter-over-quarter to $157M.
Based on Gagnon Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.